Physician profile
Connette Birl
NPI 1336779503
$2,955.20
in general payments reported to CMS, 2019-2025
15 companies · $741 in 2025
The $741 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $594 · 2023: $1,043 · 2024: $458 · 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,241.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $516.13 | 2023 | |
| Tg Therapeutics, INC. | $392.34 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $347.46 | 2022-2024 | Zeposia, Cobenfy |
| Eisai INC. | $309.66 | 2023-2025 | |
| Genentech USA, INC. | $278.70 | 2022-2025 | Ocrevus Zunovo, Ocrevus |
| Global Blood Therapeutics, INC. | $220.55 | 2021-2022 | |
| Grifols USA, LLC | $149.41 | 2025 | Gamunex-C |
| Alexion Pharmaceuticals, INC. | $135.87 | 2022-2023 | |
| Viiv Healthcare Company | $120.31 | 2025 | Cabenuva |
| Horizon Therapeutics Plc | $120.13 | 2022 | |
| Lilly USA, LLC | $120.11 | 2024 | Kisunla |
| Biogen, INC. | $118.69 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $90.85 | 2025 | |
| Janssen Biotech, INC. | $18.89 | 2024 | Tremfya |
| Argenx US, INC. | $16.10 | 2024 | Vyvgart Hytrulo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connette Birl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.